Funding Received
$16.8 Million in 2 Rounds from 1 Investor
Most Recent Funding
$5.6 Million Series B on August 20, 2013
Founded:
1996
Headquarters:
La Jolla, CA
Description:
DermTech develops and commercializes qPCR assays for skin samples using adhesive tape biopsy methods.
Categories:
Biotechnology
Website:
http://dermtech.com

Detailed Description

Update

DermTech develops and commercializes qPCR assays for skin samples collected non-invasively using adhesive tape biopsy methods. The Company’s assays can analyze multiple gene targets to assess their level of RNA expression. The Company anticipates providing these assays through a CLIA certified laboratory located in San Diego.

The Company will initially offer an assay for pigmented skin lesions sampled using an adhesive tape collection method. The Company has identified gene targets differentially expressed in melanoma samples (British Journal of Dermatology, April 2011). This assay can assess RNA expression consistent with melanoma with very high sensitivity (>95%) and specificity (>70%).

Current Team (4)

Update

Funding Rounds (2) - $5.6M

Update

Offices/Locations (1)

Update
  • Office

    11099 N. Torrey Pines Road

    Suite 100

    La Jolla, CA 92037

    USA

Images (1)

Update
  • D62f297fa305ac46044bfc50803fa354